These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 38579099

  • 1. Impact of perioperative blood transfusion on prognosis after nephrectomy in patients with renal cell carcinoma: A meta-analysis and systematic review.
    Xu J, Bai J, Pan H, Zhou Z.
    Medicine (Baltimore); 2024 Apr 05; 103(14):e37646. PubMed ID: 38579099
    [Abstract] [Full Text] [Related]

  • 2. Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis.
    Iwata T, Kimura S, Foerster B, Abufaraj M, Karakiewicz PI, Preisser F, Nasu Y, Shariat SF.
    Urol Oncol; 2019 Apr 05; 37(4):273-281. PubMed ID: 30737159
    [Abstract] [Full Text] [Related]

  • 3. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
    Seon DY, Kwak C, Kim HH, Ku JH, Kim HS.
    Investig Clin Urol; 2020 Mar 05; 61(2):136-145. PubMed ID: 32158964
    [Abstract] [Full Text] [Related]

  • 4. Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma.
    Abu-Ghanem Y, Zilberman DE, Dotan Z, Kaver I, Ramon J.
    Urol Oncol; 2018 Jan 05; 36(1):12.e15-12.e20. PubMed ID: 28993059
    [Abstract] [Full Text] [Related]

  • 5. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
    Soria F, de Martino M, Leitner CV, Moschini M, Shariat SF, Klatte T.
    Clin Genitourin Cancer; 2017 Jun 05; 15(3):e421-e427. PubMed ID: 28089722
    [Abstract] [Full Text] [Related]

  • 6. Intraoperative but not postoperative blood transfusion adversely affect cancer recurrence and survival following nephrectomy for renal cell carcinoma.
    Abu-Ghanem Y, Dotan Z, Zilberman DE, Kaver I, Ramon J.
    Sci Rep; 2019 Feb 04; 9(1):1160. PubMed ID: 30718860
    [Abstract] [Full Text] [Related]

  • 7. Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma.
    Kang HW, Seo SP, Kim WT, Yun SJ, Lee SC, Kim WJ, Hwang EC, Kang SH, Hong SH, Chung J, Kwon TG, Kim HH, Kwak C, Byun SS, Kim YJ, KORCC (KOrean Renal Cell Carcinoma) Group.
    Int J Clin Oncol; 2020 Aug 04; 25(8):1551-1561. PubMed ID: 32504136
    [Abstract] [Full Text] [Related]

  • 8. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
    Linder BJ, Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Gastineau DA, Boorjian SA.
    BJU Int; 2014 Sep 04; 114(3):368-74. PubMed ID: 24471825
    [Abstract] [Full Text] [Related]

  • 9. The effect of perioperative blood transfusion on survival after renal cell carcinoma nephrectomy: A systematic review and meta-analysis.
    Liu Y, Deng X, Wen Z, Huang J, Wang C, Chen C, Yang X.
    Front Oncol; 2023 Sep 04; 13():1092734. PubMed ID: 36874080
    [Abstract] [Full Text] [Related]

  • 10. Effect of perioperative blood transfusion on mortality for major urologic malignancies.
    Soubra A, Zabell JR, Adejoro O, Konety BR.
    Clin Genitourin Cancer; 2015 Jun 04; 13(3):e173-81. PubMed ID: 25600760
    [Abstract] [Full Text] [Related]

  • 11. Perioperative Blood Transfusion Is a Predictor of Acute and Chronic Renal Function Deterioration after Partial and Radical Nephrectomy for Renal Cell Carcinoma.
    Mühlbauer J, de Gilde J, Mueller-Steinhardt M, Porubsky S, Walach M, Nuhn P, Klüter H, Wagener N, Kriegmair MC.
    Urol Int; 2020 Jun 04; 104(9-10):775-780. PubMed ID: 32721964
    [Abstract] [Full Text] [Related]

  • 12. The Impact of Perioperative Blood Transfusion on Survival of Bladder Cancer Patients Submitted to Radical Cystectomy: Role of Anemia Status.
    Moschini M, Bianchi M, Gandaglia G, Cucchiara V, Luzzago S, Pellucchi F, Damiano R, Serretta V, Briganti A, Montorsi F, Salonia A, Colombo R.
    Eur Urol Focus; 2016 Apr 04; 2(1):86-91. PubMed ID: 28723456
    [Abstract] [Full Text] [Related]

  • 13. Impact of Perioperative Blood Transfusions on the Outcomes of Patients Undergoing Kidney Cancer Surgery: A Systematic Review and Pooled Analysis.
    Arcaniolo D, Manfredi C, Cindolo L, Marchioni M, Zukovski EP, Mirone V, Anele UA, Guruli G, Grob BM, De Sio M, Autorino R.
    Clin Genitourin Cancer; 2019 Feb 04; 17(1):e72-e79. PubMed ID: 30341027
    [Abstract] [Full Text] [Related]

  • 14. The effect of different timing of blood transfusion on oncological outcomes of patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis.
    Ma SY, An Y, Sun JX, Xu MY, Liu CQ, Xu JZ, Zhong XY, Zeng N, He HD, Xia QD, Wang SG.
    Front Oncol; 2023 Feb 04; 13():1223592. PubMed ID: 37719020
    [Abstract] [Full Text] [Related]

  • 15. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M, Schubert T, Xylinas E, Kluth L, Rouprêt M, Trinh QD, Lee RK, Al Hussein Al Awamlh B, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Karakiewicz PI, Scherr DS, Briganti A, Bachmann A, Shariat SF, UTUC Collaboration.
    Eur J Surg Oncol; 2014 Dec 04; 40(12):1693-9. PubMed ID: 24780094
    [Abstract] [Full Text] [Related]

  • 16. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, Members of the CORONA project and the SATURN project.
    Eur Urol; 2013 Sep 04; 64(3):472-7. PubMed ID: 22748912
    [Abstract] [Full Text] [Related]

  • 17. Effect of Perioperative Blood Transfusion on Prognosis after Radical Resection in Patients with Non-Metastatic Renal Cell Carcinoma: A Retrospective Analysis.
    Zhang Y, Peng Y, Liu J, Jia C, Shen B, Wang R.
    Arch Esp Urol; 2024 May 04; 77(4):412-417. PubMed ID: 38840285
    [Abstract] [Full Text] [Related]

  • 18. Predictive factors for perioperative blood transfusions in partial nephrectomy for renal masses.
    Abu-Ghanem Y, Dotan Z, Kaver I, Ramon J.
    J Surg Oncol; 2015 Oct 04; 112(5):496-502. PubMed ID: 26437866
    [Abstract] [Full Text] [Related]

  • 19. Perioperative blood transfusion and the clinical outcomes of patients undergoing cholangiocarcinoma surgery: a systematic review and meta-analysis.
    Wang Q, Du T, Lu C.
    Eur J Gastroenterol Hepatol; 2016 Nov 04; 28(11):1233-40. PubMed ID: 27560845
    [Abstract] [Full Text] [Related]

  • 20. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
    Gershman B, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC.
    Eur Urol; 2018 Dec 04; 74(6):825-832. PubMed ID: 30262341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.